hepatitis B virus articles & resources on Made-in-China.com

Diasorin Obtains Marketing Approvals for Hepatitis, Retroviral and Syphilis Assays

Feb 7, 2014

DiaSorin, a biotechnology company, has received all the marketing approvals for hepatitis, retroviral and syphilis assays on its Liaison XL platform for the Chinese market. DiaSorin is now entering the hepatitis B, hepatitis C and ...

Tags: DiaSorin, HCV, HIV, pre-surgical screening testing

Monitoring Inactive Chronic Hepatitis B (Hbv) Carriers Is a Cost-Effective Strategy

Jan 16, 2014

A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, ...

Tags: Health, Medicine

Advanced Biological Laboratories Has Acquired All The Assets of Evivar Medical

Jun 11, 2013

Advanced Biological Laboratories (ABL) has acquired all the assets of Evivar Medical (Evivar), which includes its Hepatitis B virus (HBV) and C (HCV) web-based decision support tools and the associated viral genome analysis systems (SeqHepB ...

Tags: Advanced Biological Laboratories, Evivar Medical

Spring Bank Pharmaceuticals Has Closed a $10.5m Series a Financing Round

Mar 5, 2013

US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator. The firm is planning to invest the fund in its Phase I clinical ...

Tags: Spring Bank Pharma, biopharmaceutical, healthy

FDA Has Accepted Dynavax Technologies's Heplisav BLA for Immunization Against Infection

Dec 7, 2012

The Food and Drug Administration (FDA) has accepted Dynavax Technologies' heplisav biologics license application (BLA) for immunization against infection caused by all known subtypes of hepatitis B virus in adults 18 through 70 years of ...

Tags: BLA, chronic kidney disease, hepatitis B virus

USPTO Grants a Notice of Allowance to Arrowhead's Formulation of DPC siRNA Delivery System

Nov 28, 2012

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...

Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform

EMA Has Accepted to Review The Dynavax Technologies Marketing Authorization Application

Aug 23, 2012

The European Medicines Agency (EMA) has accepted to review the Dynavax Technologies Marketing Authorization Application (MAA) for Heplisav. Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis ...

Tags: EMA, Dynax Heplisav, authorization application

Dynavax Technologies Submitted a US Biologics License Application to the FDA for HEPLISAV

Apr 27, 2012

Dynavax Technologies has submitted a US Biologics License Application (BLA) to the FDA for HEPLISAV, an investigational adult hepatitis B vaccine. In Phase III trials, HEPLISAV demonstrated higher and earlier protection with fewer ...

Tags: FDA, hepatitis B vaccine, pharmaceutical product

hepatitis B virus

Related Products